PFO ACCESS Registry
Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy
Sponsor: Abbott Medical Devices
This observational or N/A phase trial investigates Patent Foramen Ovale and Stroke and is currently ongoing. Abbott Medical Devices leads this study, which shows 10 recorded versions since 2026 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Mar 2019 — Jan 2021 [monthly]
No Longer Available
-
Feb 2019 — Mar 2019 [monthly]
No Longer Available
▶ Show 5 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
No Longer Available
-
Apr 2018 — Jun 2018 [monthly]
No Longer Available
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
No Longer Available NA
Status: Available → No Longer Available
-
Feb 2017 — Mar 2018 [monthly]
Available NA
-
Jan 2017 — Feb 2017 [monthly]
Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.